CIVAX
Price
$20.13
Change
+$0.10 (+0.50%)
Updated
Oct 15 closing price
Net Assets
2.62B
RERCX
Price
$63.44
Change
+$0.41 (+0.65%)
Updated
Oct 16 closing price
Net Assets
136.89B
Interact to see
Advertisement

CIVAX vs RERCX

Header iconCIVAX vs RERCX Comparison
Open Charts CIVAX vs RERCXBanner chart's image
American Funds International Vntg 529-A
Price$20.13
Change+$0.10 (+0.50%)
VolumeN/A
Net Assets2.62B
American Funds EUPAC R3
Price$63.44
Change+$0.41 (+0.65%)
VolumeN/A
Net Assets136.89B
CIVAX vs RERCX Comparison Chart in %
View a ticker or compare two or three
VS
CIVAX vs. RERCX commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIVAX is a Hold and RERCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERCX has more cash in the bank: 137B vs. CIVAX (2.62B). CIVAX pays higher dividends than RERCX: CIVAX (1.05) vs RERCX (0.47). CIVAX was incepted earlier than RERCX: CIVAX (6 years) vs RERCX (23 years). RERCX (1.12) is less costly to investors than CIVAX (0.98). RERCX is a more actively managed with annual turnover of: 35.00 vs. CIVAX (20.00). CIVAX (250) and RERCX (250) have matching initial minimum investment requirements. CIVAX annual gain was more profitable for investors over the last year : 16.13 vs. RERCX (11.56). CIVAX return over 5 years is better than : 38.12 vs. RERCX (12.70).
CIVAXRERCXCIVAX / RERCX
Total Expense Ratio0.981.1287%
Annual Report Gross Expense Ratio0.981.1287%
Fund Existence6 years23 years-
Gain YTD24.10621.626111%
Front Load4%N/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.62B137B2%
Annual Yield % from dividends1.050.47221%
Returns for 1 year16.1311.56140%
Returns for 3 years68.1149.19138%
Returns for 5 years38.1212.70300%
Returns for 10 yearsN/A39.87-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASPCU10.490.02
+0.19%
A SPAC III Acquisition Corp
CTSO0.91-0.01
-1.15%
Cytosorbents Corp
FLR48.46-2.27
-4.47%
Fluor Corp
DMAC6.68-0.37
-5.25%
DiaMedica Therapeutics
LOB33.03-2.94
-8.17%
Live Oak Bancshares